Cargando…
Downregulation of delta‐aminolevulinate dehydratase is associated with poor prognosis in patients with breast cancer
Delta‐aminolevulinate dehydratase (ALAD) catalyzes the second step in the biosynthesis of heme and is also an endogenous inhibitor of the 26S proteasome. The role of ALAD in breast cancer progression is still unclear. In this study, we found that the expression of ALAD was downregulated in breast ca...
Autores principales: | Ge, Jie, Yu, Yue, Xin, Fei, Yang, Zheng‐Jun, Zhao, Hong‐Meng, Wang, Xin, Tong, Zhong‐Sheng, Cao, Xu‐Chen |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5406535/ https://www.ncbi.nlm.nih.gov/pubmed/28403546 http://dx.doi.org/10.1111/cas.13180 |
Ejemplares similares
-
Regulation of Delta-Aminolevulinic Acid Dehydratase by Krüppel-Like Factor 1
por: Desgardin, Aurelie D., et al.
Publicado: (2012) -
Influence of the common human delta-aminolevulinate dehydratase polymorphism on lead body burden.
por: Wetmur, J G
Publicado: (1994) -
Longitudinal Study of Delta-Aminolevulinate Dehydratase Activity and Oxidative Profile in Healthy Pregnant Women
por: de Lucca, Leidiane, et al.
Publicado: (2019) -
Association between Blood Lead Levels and Delta-Aminolevulinic Acid Dehydratase in Pregnant Women
por: La-Llave-León, Osmel, et al.
Publicado: (2017) -
A polymorphism in the delta-aminolevulinic acid dehydratase gene may modify the pharmacokinetics and toxicity of lead.
por: Smith, C M, et al.
Publicado: (1995)